+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Refractive Surgery Devices Market By Application, By Product, By End Use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 91 Pages
  • September 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5472737

The North America Refractive Surgery Devices Market is expected to witness market growth of 8.6% CAGR during the forecast period (2021-2027).

Refractive surgeries are performed to correct or improve refractive errors like presbyopia, astigmatism, farsightedness (hyperopia), and near-sightedness (myopia). There are many types of devices used to perform these surgeries are femtosecond lasers, YAG lasers, microkeratomes, and excimer lasers.

The determinants like technological developments in LASIK surgery, rising number of incidences of ophthalmic diseases, and huge population wearing spectacles are expected to fuel the refractive surgery devices market in the upcoming years. This market will possibly raise awareness among the population about new treatment options & the latest developments in the devices and display lucrative opportunities for markets that are still unused.

North America is a developed region and major market players exist in this region. The growing population and surge in technological advancement are driving the growth of the regional market. As the technologies are getting advanced, people are making full use of them and spending more time on digital devices that are gradually affecting their eyesight and creating eye problems. Along with this, there is an increase in the aging population, which is accountable for surging the demand for surgical devices and hence, driving the growth of the regional market.

Further, the availability of reimbursement policies, the rising number of hospitals, and the increasing rate of incidents is expected to propel the demand for surgical devices in this region. Another factor attributed to surge in the market growth is the trend of working from home. The number of the workforce in this region is spending more time on desktop and laptop that is straining their eye-sight. Thus, there is an increase in the number of patients suffering from eye problems and therefore, propelling the growth of the refractive surgery devices market in this region.

The USA market dominated the North America Hyperopia Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $21,430.8 Thousands by 2027. The Canada market is experiencing a CAGR of 8.4% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 10.6% during (2021 - 2027).

Based on Application, the market is segmented into Astigmatism, Myopia, Hyperopia, Presbyopia, and Dry eyes. Based on Product, the market is segmented into Lasers, Microkeratome, Aberrometers and Other Products. Based on End Use, the market is segmented into Ophthalmology Clinics, Hospitals and Ambulatory surgery centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).



Scope of the Study


Market Segments Covered in the Report:


By Application

  • Astigmatism
  • Myopia
  • Hyperopia
  • Presbyopia, and
  • Dry eyes

By Product

  • Lasers
  • Microkeratome
  • Aberrometers and
  • Other Products

By End Use

  • Government
  • Energy
  • Defense
  • Agriculture & Forestry
  • Media & Entertainment
  • Civil Engineering & Archaeology
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:


  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Novartis AG
  • Glaukos Corporation
  • Johnson & Johnson
  • EssilorLuxottica SA
  • Bausch Health Companies, Inc.
  • SCHWIND Eye-Tech-Solutions GmbH
  • NIDEK CO., LTD.
  • Quantel Medical (Lumibird Group)

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Refractive Surgery Devices Market, by Application
1.4.2 North America Refractive Surgery Devices Market, by Product
1.4.3 North America Refractive Surgery Devices Market, by End Use
1.4.4 North America Refractive Surgery Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2017,Feb - 2021, Jul) Leading Players
Chapter 4. North America Refractive Surgery Devices Market by Application
4.1 North America Astigmatism Market by Country
4.2 North America Myopia Market by Country
4.3 North America Hyperopia Market by Country
4.4 North America Presbyopia Market by Country
4.5 North America Dry eyes Market by Country
Chapter 5. North America Refractive Surgery Devices Market by Product
5.1 North America Lasers Market by Country
5.2 North America Microkeratome Market by Country
5.3 North America Aberrometers Market by Country
5.4 North America Other Products Market by Country
Chapter 6. North America Refractive Surgery Devices Market by End Use
6.1 North America Ophthalmology Clinics Market by Country
6.2 North America Hospitals Market by Country
6.3 North America Ambulatory surgery centers Market by Country
Chapter 7. North America Refractive Surgery Devices Market by Country
7.1 USA Refractive Surgery Devices Market
7.1.1 USA Refractive Surgery Devices Market by Application
7.1.2 USA Refractive Surgery Devices Market by Product
7.1.3 USA Refractive Surgery Devices Market by End Use
7.2 Canada Refractive Surgery Devices Market
7.2.1 Canada Refractive Surgery Devices Market by Application
7.2.2 Canada Refractive Surgery Devices Market by Product
7.2.3 Canada Refractive Surgery Devices Market by End Use
7.3 Mexico Refractive Surgery Devices Market
7.3.1 Mexico Refractive Surgery Devices Market by Application
7.3.2 Mexico Refractive Surgery Devices Market by Product
7.3.3 Mexico Refractive Surgery Devices Market by End Use
7.4 Rest of North America Refractive Surgery Devices Market
7.4.1 Rest of North America Refractive Surgery Devices Market by Application
7.4.2 Rest of North America Refractive Surgery Devices Market by Product
7.4.3 Rest of North America Refractive Surgery Devices Market by End Use
Chapter 8. Company Profiles
8.1 Carl Zeiss Meditec AG (Carl Zeiss AG)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 Recent Strategies and Developments:
8.1.5.1 Acquisitions and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Topcon Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Recent Strategies and Developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Acquisitions and Mergers:
8.3 Novartis AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent Strategies and Developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Glaukos Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Johnson & Johnson
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental &Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and Developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Geographical Expansions:
8.6 EssilorLuxottica SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent Strategies and Developments:
8.6.5.1 Acquisitions and Mergers:
8.7 Bausch Health Companies, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and Developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product launches and Product Expansions:
8.8 SCHWIND Eye-Tech-Solutions GmbH
8.8.1 Company Overview
8.9 Nidek Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent Strategies and Developments:
8.9.2.1 Product Launches and Product Expansions:
8.10. Quantel Medical (Lumibird Group)
8.10.1 Company Overview

Companies Mentioned

  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Novartis AG
  • Glaukos Corporation
  • Johnson & Johnson
  • EssilorLuxottica SA
  • Bausch Health Companies, Inc.
  • SCHWIND Eye-Tech-Solutions GmbH
  • NIDEK CO., LTD.
  • Quantel Medical (Lumibird Group)

Methodology

Loading
LOADING...